Javier Martín-López, Federico Rojo, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucía Ruiz de Alda, J Francisco García & Clara Salas. (2023) Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP). Journal of Clinical Pathology 76:5, pages 327-332.
Crossref
Saumya Srivastava & Anjana Pandey. 2023. Oncology: Genomics, Precision Medicine and Therapeutic Targets. Oncology: Genomics, Precision Medicine and Therapeutic Targets
1
24
.
Clara Salas, Javier Martín-López, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucia Ruiz de Alda, J Francisco García & Federico Rojo. (2022) Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP). Journal of Clinical Pathology 75:3, pages 193-200.
Crossref
Alexander Zarbock. (2021) The Journey Begins: Personalized Acute Kidney Injury Therapy*. Critical Care Medicine 49:10, pages 1822-1825.
Crossref
Yingxin Kan, Limin Jiang, Jijun Tang, Yan Guo & Fei Guo. (2021) A systematic view of computational methods for identifying driver genes based on somatic mutation data. Briefings in Functional Genomics 20:5, pages 333-343.
Crossref
Tianxi Cai, T. Tony Cai & Zijian Guo. (2021) Optimal Statistical Inference for Individualized Treatment Effects in High-Dimensional Models. Journal of the Royal Statistical Society Series B: Statistical Methodology 83:4, pages 669-719.
Crossref
Hariharan Moorthy & Thimmaiah Govindaraju. (2021) Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine. ACS Applied Bio Materials 4:2, pages 1115-1139.
Crossref
Marios Spanakis, Athina E. Patelarou & Evridiki Patelarou. (2020) Nursing Personnel in the Era of Personalized Healthcare in Clinical Practice. Journal of Personalized Medicine 10:3, pages 56.
Crossref
Narges Aberuyi, Soheila Rahgozar, Elaheh Sadat Ghodousi & Kamran Ghaedi. (2020) Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia. Frontiers in Oncology 9.
Crossref
Saima Shakil Malik, Iqra, Nosheen Akhtar, Iffat Fatima, Zaineb Akram & Nosheen Masood. 2020. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine
313
332
.
Allen D. Everett, Shama S. Alam, Sherry L. Owens, Devin M. Parker, Christine Goodrich, Donald S. Likosky, Heather Thiessen-Philbrook, Moritz Wyler von Ballmoos, Kevin Lobdell, Todd A. MacKenzie, Jeffrey Jacobs, Chirag R. Parikh, Anthony W. DiScipio, David J. Malenka & Jeremiah R. Brown. (2019) The Association between Cytokines and 365-Day Readmission or Mortality in Adult Cardiac Surgery. The Journal of ExtraCorporeal Technology 51:4, pages 201-209.
Crossref
Marta Molina Romero, Emilio José Laserna Mendieta, Gema María Varo Sánchez, María Concepción Alonso-Cerezo & María Orera Clemente. (2019) Oncología personalizada: principales biomarcadores en el pronóstico y tratamiento de tumores sólidos. Revista del Laboratorio Clínico 12:3, pages e1-e8.
Crossref
Rafael Selbach Scheffel & Ana Luiza Maia. (2019) The long and still uncertain journey of BRAF as a prognostic tool in patients with papillary thyroid cancer. Archives of Endocrinology and Metabolism 63:2, pages 95-96.
Crossref
Wendy Yang & Michael F. Berger. 2019. Precision Cancer Medicine. Precision Cancer Medicine
5
31
.
Mohammad Al-Kaiyat. (2018) Precision Coordination: The Growing Role of the Nurse Coordinator in the Era of Personalized Medicine
. Clinical Journal of Oncology Nursing 22:1, pages 113-115.
Crossref
. 2018. Diagnostic Pathology: Cytopathology. Diagnostic Pathology: Cytopathology
730
733
.
L. V. K. S. Bhaskar & L. Saikrishna. 2018. Role of Tyrosine Kinases in Gastrointestinal Malignancies. Role of Tyrosine Kinases in Gastrointestinal Malignancies
191
224
.
Yongkuan Cao, Guohu Zhang, Peihong Wang, Jun Zhou, Wei Gan, Yaning Song, Ling Huang, Ya Zhang, Guode Luo, Jiaqing Gong & Lin Zhang. (2017) Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer. BMC Gastroenterology 17:1.
Crossref
Sally Safwat, Rania A Ishak, Rania M Hathout & Nahed D Mortada. (2017) Statins anticancer targeted delivery systems: re-purposing an old molecule. Journal of Pharmacy and Pharmacology 69:6, pages 613-624.
Crossref
Brett Doble, Thomas John, David Thomas, Andrew Fellowes, Stephen Fox & Paula Lorgelly. (2017) Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing. Lung Cancer 107, pages 22-35.
Crossref
Marcin Opławski, Mateusz Michalski, Andrzej Witek, Bogdan Michalski, Nikola Zmarzły, Agnieszka Jęda-Golonka, Maria Styblińska, Joanna Gola, Małgorzata Kasprzyk-Żyszczyńska, Urszula Mazurek & Andrzej Plewka. (2017) Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer. Molecular Medicine Reports 16:3, pages 2547-2555.
Crossref
Yuanyuan ShenTianxi Cai. (2016) Identifying predictive markers for personalized treatment selection. Biometrics 72:4, pages 1017-1025.
Crossref
Xue Qiu, K. David Wegner, Yu-Tang Wu, Paul M. P. van Bergen en Henegouwen, Travis L. Jennings & Niko Hildebrandt. (2016) Nanobodies and Antibodies for Duplexed EGFR/HER2 Immunoassays Using Terbium-to-Quantum Dot FRET. Chemistry of Materials 28:22, pages 8256-8267.
Crossref
Hyo Sook Han & Anthony M. Magliocco. (2016) Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer. Clinical Breast Cancer 16:3, pages 166-179.
Crossref
Jin-hui Liu, Pei Xi, Yan-lan Chai, Juan Wang, Tao Wang, Zi Liu & Peng-gao Dai. (2016) Association of DNA repair gene polymorphisms with response to cisplatin-based concurrent chemoradiotherapy in patients with cervical carcinoma. DNA Repair 41, pages 69-72.
Crossref
AnXiu Gao, YunLi Tian, ZhuanZhuan Shi & Ling Yu. (2015) A cost-effective microdevice bridges microfluidic and conventional in vitro scratch / wound-healing assay for personalized therapy validation. BioChip Journal 10:1, pages 56-64.
Crossref
Mahendran Botlagunta. 2016. Nutraceuticals. Nutraceuticals
783
839
.
Urszula Demkow. 2016. Clinical Applications for Next-Generation Sequencing. Clinical Applications for Next-Generation Sequencing
217
240
.
Dinko Vitezić, Nada Božina, Jasenka Mršić-Pelčić, Viktorija Erdeljić Turk & Igor Francetić. 2016. Personalized Medicine. Personalized Medicine
265
278
.
Qing Liu, Swee Yin Lim, Ross A. Soo, Mi Kyoung Park & Yong Shin. (2015) A rapid MZI-IDA sensor system for EGFR mutation testing in non-small cell lung cancer (NSCLC). Biosensors and Bioelectronics 74, pages 865-871.
Crossref
S. Scarano, S. Mariani & M. Minunni. 2015. Advanced Bioelectronic Materials. Advanced Bioelectronic Materials
55
88
.
Daniela Sia, Agrin Moeini, Ismail Labgaa & Augusto Villanueva. (2015) The future of patient-derived tumor xenografts in cancer treatment. Pharmacogenomics 16:14, pages 1671-1683.
Crossref
Thomas K. Karikari, Emmanuel Quansah & Wael M.Y. Mohamed. (2015) Widening participation would be key in enhancing bioinformatics and genomics research in Africa. Applied & Translational Genomics 6, pages 35-41.
Crossref
SHUN-ICHI SUZUKI, SATOSHI MATSUSAKA, MITSUHARU HIRAI, HARUMI SHIBATA, KOICHI TAKAGI, NOBUYUKI MIZUNUMA & KIYOHIKO HATAKE. (2015) A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction. International Journal of Oncology 47:1, pages 97-105.
Crossref
Marilyn Tsourounis, Jeffrey Stuart, William Pignato, Michael Toscani & Joseph Barone. (2015) Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics. Therapeutic Innovation & Regulatory Science 49:4, pages 530-543.
Crossref
Katherine M Keyes, George Davey Smith, Karestan C Koenen & Sandro Galea. (2015) The mathematical limits of genetic prediction for complex chronic disease. Journal of Epidemiology and Community Health 69:6, pages 574-579.
Crossref
Juan Wang, Yan-lan Chai, Tao Wang, Jin-hui Liu, Peng-gao Dai & Zi Liu. (2015) Genetic alterations of PIK3CA and tumor response in patients with locally advanced cervical squamous cell carcinoma treated with cisplatin-based concurrent chemoradiotherapy. Experimental and Molecular Pathology 98:3, pages 407-410.
Crossref
Kunitoshi Shigeyasu, Hiroshi Tazawa, Yuuri Hashimoto, Yoshiko Mori, Masahiko Nishizaki, Hiroyuki Kishimoto, Takeshi Nagasaka, Shinji Kuroda, Yasuo Urata, Ajay Goel, Shunsuke Kagawa & Toshiyoshi Fujiwara. (2015) Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics. Gut 64:4, pages 627-635.
Crossref
Mei Haruya & Shingo Kano. (2015) A new look at the corporate capability of personalized medicine development in the pharmaceutical industry. R&D Management 45:1, pages 94-103.
Crossref
Takeki Uehara, Yuping Wang & Weida Tong. 2015. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications
75
109
.
Athina Markou, Ioanna Sourvinou, Ioanna Balkouranidou & Evi S. Lianidou. 2015. Biomarkers in Cancer. Biomarkers in Cancer
325
344
.
Carleton T. Garrett. 2015. Molecular Oncology Testing for Solid Tumors. Molecular Oncology Testing for Solid Tumors
3
65
.
Taofic Mounajjed, Char L. Brown, Therese K. Stern, Annette M. Bjorheim, Andrew J. Bridgeman, Kandelaria M. Rumilla, Robert R. McWilliams & Thomas J. Flotte. (2014) Preappointment testing for BRAF/KIT mutation in advanced melanoma: a model in molecular data delivery for individualized medicine. Human Pathology 45:11, pages 2240-2246.
Crossref
Jeffrey Tobias & Daniel Hochhauser. 2014. Cancer and its Management. Cancer and its Management
81
112
.
João Renato Rebello Pinho, Roberta Sitnik & Cristóvão Luis Pitangueira Mangueira. (2014) Personalized medicine and the clinical laboratory. Einstein (São Paulo) 12:3, pages 366-373.
Crossref
Laura Wayteck, Karine Breckpot, Jo Demeester, Stefaan C. De Smedt & Koen Raemdonck. (2014) A personalized view on cancer immunotherapy. Cancer Letters 352:1, pages 113-125.
Crossref
Henrica M. J. Werner, Jone Trovik, Mari K. Halle, Elisabeth Wik, Lars A. Akslen, Even Birkeland, Therese Bredholt, Ingvild L. Tangen, Camilla Krakstad & Helga B. Salvesen. (2014) Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer. PLoS ONE 9:2, pages e90141.
Crossref
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly & Omid C. Farokhzad. (2014) Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews 66, pages 2-25.
Crossref
D.C. Anderson & Krishna Kodukula. (2014) Biomarkers in pharmacology and drug discovery. Biochemical Pharmacology 87:1, pages 172-188.
Crossref
Athina Markou, Ioanna Sourvinou, Ioanna Balkouranidou & Evi S. Lianidou. 2014. Biomarkers in Cancer. Biomarkers in Cancer
1
16
.
Takeki Uehara, Yuping Wang & Weida Tong. 2014. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications
1
25
.
Richard A. Scolyer, Klaus J. Busam & Raymond L. Barnhill. 2014. Pathology of Melanocytic Nevi and Melanoma. Pathology of Melanocytic Nevi and Melanoma
529
567
.
Soya S. Sam & Gregory J. Tsongalis. 2014. Molecular Testing in Cancer. Molecular Testing in Cancer
405
421
.
Kitchener D. Wilson & Iris Schrijver. 2014. Molecular Testing in Cancer. Molecular Testing in Cancer
3
13
.
Xia Pu, Yuanqing Ye & Xifeng Wu. (2014) Development and validation of risk models and molecular diagnostics to permit personalized management of cancer. Cancer 120:1, pages 11-19.
Crossref
L. Fashoyin-Aje, K. Sanghavi, K. Bjornard & J. Bodurtha. (2013) Integrating genetic and genomic information into effective cancer care in diverse populations. Annals of Oncology 24, pages vii48-vii54.
Crossref
Hiroaki Nitta, Koji Tsuta, Akihiko Yoshida, Steffan N. Ho, Brian D. Kelly, Lauren B. Murata, Jerry Kosmeder, Katie White, Sandra Ehser, Penny Towne, Crystal Schemp, Abigail McElhinny, Jim Ranger-Moore, Chris Bieniarz, Shalini Singh, Hitoshi Tsuda & Thomas M. Grogan. (2013) New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer: An Improved ALK Immunohistochemical Assay and a New, Brightfield, Dual ALK IHC–In Situ Hybridization Assay. Journal of Thoracic Oncology 8:8, pages 1019-1031.
Crossref
Jeanette J. McCarthyHoward L. McLeodGeoffrey S. Ginsburg. (2013) Genomic Medicine: A Decade of Successes, Challenges, and Opportunities. Science Translational Medicine 5:189.
Crossref
Howard I. Scher, Michael J. Morris, Steven Larson & Glenn Heller. (2013) Validation and clinical utility of prostate cancer biomarkers. Nature Reviews Clinical Oncology 10:4, pages 225-234.
Crossref
Frank Ong, Jane Kuo, Wei-Chi Wu, Ching-Yu Cheng, Wendell-Lamar Blackwell, Brian Taylor, Wayne Grody, Jerome Rotter, Chi-Chun Lai & Tien Wong. (2013) Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. Journal of Personalized Medicine 3:1, pages 40-69.
Crossref
John B. McIntyre, Jackson S. Wu, Peter S. Craighead, Tien Phan, Martin Köbel, Susan P. Lees-Miller, Prafull Ghatage, Anthony M. Magliocco & Corinne M. Doll. (2013) PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy. Gynecologic Oncology 128:3, pages 409-414.
Crossref
Jennifer L. Harris, Michael Stocum, Lisa Roberts, Chunsheng Jiang, Jessie Lin & Kam Sprott. (2013) Quest for the Ideal Cancer Biomarker: An Update on Progress in Capture and Characterization of Circulating Tumor Cells. Drug Development Research 74:2, pages 138-147.
Crossref
S. Souchelnytskyi. (2013) INDIVIDUALIZATION OF CANCER TREATMENT: CONTRIBUTION OF OMICS TECHNOLOGIES TO CANCER DIAGNOSTIC. Biotechnologia Acta 6:4, pages 105-117.
Crossref
Guang Hu, Yuqian Li & Bairong Shen. 2013. Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases. Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases
189
205
.